An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries.

Abstract

OBJECTIVE To examine the preference for 2 dosing regimens (on demand or 3 times/week) for tadalafil, a phosphodiesterase 5 inhibitor with a duration of effectiveness up to 36 hours in men with erectile dysfunction (ED). DESIGN AND METHODS SURE is a 14 European country, multicenter, crossover, and open-label study. Men with ED (N=4262) were randomized to… (More)

Topics

Cite this paper

@article{Mirone2005AnEO, title={An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries.}, author={Vincenzo G Mirone and Pierre Costa and J E Damber and Simon C. Holmes and Ignacio Moncada and Hermann van Ahlen and Eric Wespes and William H. Cordell and Melanie L-S Chan and Danilo Lembo and Lucio Varanese}, journal={European urology}, year={2005}, volume={47 6}, pages={846-54; discussion 854} }